Myomo (MYO) Notes Payables (2016 - 2020)

Myomo (MYO) reported Notes Payables of $78045.0 for Q3 2020, down 92.17% quarter-over-quarter from $996841.0 in Q2 2020.

Myomo (MYO) Notes Payables (2016 - 2020) Analysis & Trends

Myomo has reported Notes Payables for 4 years, with the latest figure at $78045.0 in Q3 2020.

  • For the quarter ending Q3 2020, Notes Payables changed N/A year-over-year to $78045.0; the trailing twelve-month figure through Sep 2020 stood at $78045.0 (changed N/A YoY), and the FY2019 full-year result was $1.8 million, changed N/A from the prior year.
  • Notes Payables for Q3 2020 stood at $78045.0, down from $996841.0 in the prior quarter.
  • The five-year high for Notes Payables was $1.8 million in Q4 2019, with the low at $78045.0 in Q3 2020.
  • Historically, Notes Payables has averaged $859206.2 across 4 years, with a median of $876458.0 in 2016.
  • The largest YoY upside for Notes Payables was 33.73% in 2017 against a maximum downside of 33.73% in 2017.
  • Myomo's Notes Payables stood at $876458.0 in 2016, then sank by 33.73% to $580800.0 in 2017, then jumped by 203.7% to $1.8 million in 2019, then tumbled by 95.58% to $78045.0 in 2020.
  • The last three Notes Payables figures came in at $78045.0 (Q3 2020), $996841.0 (Q2 2020), and $1.8 million (Q4 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Myomo 49.44 Mn 31.04 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 78,045.00
Jun 30, 2020 996,841.00
Dec 31, 2019 1.76 Mn
Dec 31, 2017 580,800.00
Dec 31, 2016 876,458.00